Modern treatment modalities for neonatal and pediatric respiratory failure.

Abstract

BACKGROUND:

Respiratory failure secondary to a variety of causes remains a significant cause of morbidity and mortality in the pediatric population. Newer therapies are appearing frequently in an attempt to decrease the number of deaths from this disease state. We briefly review the current literature on some of the newer modalities including: high-frequency ventilation, surfactant, liquid ventilation, and nitric oxide. We then present our experience from the past 11 years in the most invasive, yet successful, therapy for acute respiratory failure-extracorporeal membrane oxygenation (ECMO).

METHODS:

Retrospective review of all patients treated with ECMO from September 1983 to December 1994 was undertaken. Data were collected from bedside ECMO flow sheets and the standardized data entry forms submitted to the Extracorporeal Life Support Organization. All statistical analyses were performed using a standard statistical software program.

RESULTS:

During the study period, 194 neonates and 47 pediatric patients were treated with ECMO. The survival rate in the neonatal population is 82% and in the pediatric population it is 40%. The neonatal patients required an average of 153 hours of support while the pediatric patients required 220 hours (P = 0.008).

CONCLUSIONS:

While the newer treatment modalities discussed may have an important role in treating neonatal and pediatric respiratory failure in the near future, ECMO remains a cornerstone of the modern treatment modalities. Although somewhat invasive, ECMO is effective therapy with increasing survival rates each year.

• Authors: R M Arensman, M B Statter, A L Bastawrous, M B Madonna
• Journal: American journal of surgery (Am J Surg) Vol. 172 Issue 1 Pg. 41-7 (Jul 1996) ISSN: 0002-9610 [Print] United States
• PMID: 8686800 (Publication Type: Journal Article)

Chemical References

• Pulmonary Surfactants
• Nitric Oxide

Topics

• Child
• Child, Preschool
• Extracorporeal Membrane Oxygenation
• Humans
• Infant
• Infant, Newborn
• Nitric Oxide (therapeutic use)
• Pulmonary Surfactants (therapeutic use)
• Respiration, Artificial
• Respiratory Insufficiency (therapy)
• Retrospective Studies
• Treatment Outcome